News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
191 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (22766)
Month
January (2433)
February (2868)
March (3029)
April (3116)
May (3356)
June (2727)
July (2287)
August (2493)
September (457)
Day
1 (65)
3 (19)
4 (205)
5 (197)
6 (190)
7 (229)
8 (170)
10 (33)
11 (150)
12 (194)
13 (208)
14 (261)
15 (58)
17 (52)
18 (160)
19 (145)
20 (146)
21 (119)
22 (102)
24 (37)
25 (10)
26 (177)
27 (191)
28 (158)
29 (79)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
Day
1
3
4
5
6
7
8
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
31
Rare diseases
FDA accepts BridgeBio’s application for potential first limb-girdle muscular dystrophy drug
The FDA’s priority review acceptance of BridgeBio’s BBP-418 is another step toward what William Blair previously dubbed a “diversified commercial portfolio.” It also adds to the rapidly building momentum in muscular dystrophy more broadly.
May 27, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Solu Therapeutics Granted FDA Fast Track Designation for STX-0712 for Treatment of Chronic Myelomonocytic Leukemia
May 27, 2026
·
2 min read
Press Releases
Sana Biotechnology to Present at June 2026 Investor Conferences
May 27, 2026
·
3 min read
Press Releases
Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees
May 27, 2026
·
25 min read
Press Releases
ORIC® Pharmaceuticals to Participate in Upcoming June 2026 Investor Conferences
May 27, 2026
·
1 min read
Press Releases
Aktis Oncology to Present at the Jefferies Global Healthcare Conference 2026
May 27, 2026
·
2 min read
Press Releases
Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy
May 27, 2026
·
9 min read
Press Releases
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June 2026
May 27, 2026
·
1 min read
Press Releases
Ligand to Participate in June 2026 Investor Conferences
May 27, 2026
·
1 min read
Press Releases
MannKind to Present at Jefferies Global Healthcare Conference 2026
May 27, 2026
·
1 min read
Previous
18 of 20
Next
